Bordeaux University Hospital
Pessac, France, 33604
NCT Number: NCT06272344
Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators need to be regularly and systematically interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full CIED check-up and reprogramming is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. The aim of this study is to evaluate our previously validated remote programming solution (REACT study, NCT05366660) in outpatient device clinics which are close to the patient's home but remote from the CIED expert.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pessac, France, 33604
Remote programming of a CIED offers multiple advantages such as shorter travel distances for the patient, reduced need for presence of specialized cardiologists and the possibility to offer expert support at remote locations or developing countries. Remote programming may be a way to mitigate disparities in health care access. The remote surveillance centre of CHU Bordeaux has previously developed and validated (REACT study, NCT05366660) a remote control system for CIED programmers that eliminates the physical presence of a cardiologist during the interrogation and programming process. The aim of this study is to evaluate this solution for the remote evaluation of CIEDs at the benefit of inhabitant of medically underserved population. Enrolled patients living >100km from the Bordeaux University Hospital will undergo there an in person evaluation of their CIED which will be compared six months later with a remote evaluation in a nurse office close to the patient's home.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Teleconsultation at 6 months
Time frame: 6 months
Patient satisfaction
Time frame: 6 months
Time of consultation and teleconsultation
Time frame: 6 months
Cost of medical transports for consultation and teleconsultation
Time frame: 6 months
Global amount of costs for teleconsultation
Time frame: 6 months
Number of Adverse Events and technical incidents
University Hospital, Bordeaux
Other
Acronym: REACT 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02548819
Defibrillator, MRI
Augusta, Georgia, United States
View Trial DetailsNCT04870424
Atrial Fibrillation New Onset, Colchicine
Bern, Switzerland
View Trial DetailsNCT06775691
Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator
Çorum, Center, Turkey (Türkiye)
View Trial DetailsNCT07477964
Adherence, Patient, Behavior
San Francisco, California, United States
View Trial Details